Topics
Social determinants of health
Commercial determinants of human rights: for‐profit health care and housing
What do the commercial determinants of health look like for goods and services that are human rights?
Jennifer Lacy‐Nichols · Rebecca Bentley · Adam G Elshaug
Centring equity in data‐driven public health: a call for guiding principles to support the equitable design and outcomes of Australia's data integration systems
We need to design data systems that hold social and health equity as a core value and desired outcome of data integration
Catherine Smith · Claire M Vajdic · Niamh Stephenson
The NDIS at ten years: designing an equitable scheme for the next decade
As the NDIS turns ten, we must make changes to improve scheme equity The National Disability Insurance Scheme (NDIS) was created to provide reasonable and necessary supports for people with disability under the age of 65 years to live an included and meaningful life on an equal basis with other Australians. The mechanism for this is individualised support plans underpinned by personal budgets that are spent on services purchased from a social care market. Former Prime Minister Julia Gillard announced the scheme in 2012 and the national roll‐out, which began in 2013, was achieved in July 2020.1 The NDIS is a very significant social policy innovation and its importance for people with disability in Australia cannot be underestimated. For many people with disability, the supports provided through the NDIS have been essential to living an included life. The scheme was funded in part by an increase in the Medicare Levy, against which there was little initial protest.2 However, providing these essential supports has been more costly than originally anticipated by the Productivity Commission.3 The NDIS is expected to cost $50 billion annually by 2024–2025,4 which is higher than the annual budget for either Medicare or defence. Attention to the scheme costs has been mounting, along with attendant fears about cost‐cutting to plans.5 This has caused mistrust, with fear over cost‐cutting to and by the NDIS a factor in community rejection of the now cancelled “independent assessments”.6 Even with expanding costs there remains significant concerns about equity within the scheme, with some groups still failing to receive the services that they need in comparison with others. To address these and other concerns, such as access, market and workforce, the federal government has initiated an independent review into the NDIS. Who is in? Who is out? There are over 535000 NDIS participants compared with almost 4.4 million people with disability in Australia, including 2.4 million aged under 65 years,7 which means the NDIS can only ever be part of the national disability support landscape. Yet in the early days of its implementation, it became the default disability system as other existing disability supports and approaches were defunded or removed. These supports included successful programs such as Partners in Recovery, which was defunded when most existing participants were not eligible for the NDIS.8,9 This has led to a situation where the NDIS is, as Bruce Bonyhady, the original Chair of the National Disability Insurance Agency, calls it, an “oasis in the desert”,10 with scheme participants receiving support to a much higher level than non‐participants. This situation makes people currently eligible desperate to retain NDIS supports and others desperate to become eligible.11 A Tier 2 scheme was originally envisioned to provide referrals and community assistance so that people not eligible for individual NDIS plans could receive support. However, the Tier 2 scheme has not been effective in delivering this.10 Current NDIS participants are overwhelmingly young (under 18 years) and male, which is driven by the large number of participants with autism and developmental delay.12,13 Participants with a primary autism diagnosis comprise 30.9% of scheme participants, followed by intellectual disability (20.2%) and psychosocial disability (9.1%). Eighty‐nine per cent of men aged over 18 years have applications for access approved compared with 80% of women.13 Just 37% of NDIS participants are women — substantially lower than the 49% of people with disability aged under 65 years who are women.14,13 This raises concerns that the intersectional influence of gender might drive disparities in access.15 Concerns about utilisation and support Concerns have been raised about scheme access and utilisation of approved plans (ie, percentage of budgeted supports used), which are lower in some participant groups compared with others, resulting in inequity of access to necessary supports.16 Although utilisation is not a perfect measure because it relies on planning processes that may in themselves be inequitable, it is clear that utilisation differs by disability type; for example, people with psychosocial disability have an average plan utilisation of 53% compared with 70% for those with autism.17 A major factor in the disparity in plan utilisation is due to the failure of markets to function where participant needs necessitate more specialised supports, which come at higher costs to providers, and in areas where there are poor economies of scale.18,19 Plan utilisation is higher for people in metropolitan than regional and remote areas (eg, only 11% plan utilisation for people with psychosocial disability in the Far West region of New South Wales).20 Interestingly, some populations that are traditionally underserved in health and social care receive good access to the NDIS, with culturally and linguistically diverse people with disability having higher than average plan spending and utilisation.17 This may be a function of rurality, with most of this population resident in metropolitan areas.17 Differences in use of plans, for some groups of people with disability compared with others, underline the fact that the scheme functions better for people with support needs that are relatively straightforward and can receive support from less specialised, more generic services and support workers. In an exploration of plan utilisation by people with psychosocial disability, a 2022 study found that utilisation of plans is affected by both individual and broader systemic conditions, including available workforce.21 Workforce planning to ensure more equitable access for people with more complex needs is therefore one part of the strategy for addressing this deficit.22 Much of the NDIS workforce do not have specialised qualifications in disability, which makes them an easier workforce to come by and a workforce that is therefore cheaper for services to employ compared with experienced or qualified workers (and with wage costs reduced, enables easier profits). This can mean that the quality of support is lower even for those with lower support needs because the workforce may have limited knowledge of disability and have low expectations of what people with disability want and need to do, for example, beyond assisted showers, walks around the neighbourhood, and some social conversation. Participants prefer experience specific to their needs.23 Relevant experience does not necessarily come from training but may come from lived experience of disability and disability support, with many people prioritising interpersonal skills over qualifications in disability.24 Without an experienced workforce, people with complex language and communication disability (including one of the authors of this article with deaf‐blindness), for instance, will not have their needs understood and so remain marginalised. There is a fear that ill‐informed service providers sometimes act as gatekeepers denying supports that people with disability, the true experts, know they need: “They need to be able to have walked in our shoes”.25 These workforce deficiencies are structural problems enabled by deficiencies in the market structure that accompanies the NDIS and must be addressed to provide equity for people with disability.26 Aboriginal and Torres Strait Islander people with disability There are also cultural barriers to equity in the operation of the NDIS, with lower levels of plan utilisation in Indigenous people with disability.17 There are a number or reasons for this, including the number of Indigenous people living outside of major cities (56.8% v 31.6% non‐Indigenous) and in remote areas (9.8% v 0.8%).17 NDIS planning processes are fraught with challenges for Indigenous people living in regional and remote areas. The process of providing evidence of disability often causes significant stress and trauma.27,28 The principle and process of providing evidence is situated in a deficit model, requiring people to prove the experience of disability as a burden. This model of disability is the antithesis of Indigenous cultural ways of experiencing disability where disability is interpreted as part of the diverse human experience as opposed to a limitation or impediment.27,28 The NDIS is also designed on Western‐centric assumptions that all people with disability exist at the same starting line: house, shelter, food, family support. Many Indigenous people with disability are homeless, living in poverty or in overcrowded houses.29,30,31 To address equity for this group there needs to be Indigenous‐controlled service providers who generate whole‐of‐life case management to help Indigenous people with disability who are living in disadvantage understand and access the scheme.32 What next? Inherent in these tensions is a concern that a scheme that should be agnostic to diagnosis and provide support based on individual needs does not work well for those with more complex needs or whose experiences do not fit mainstream ways of understanding or experiencing disability. The NDIS is one mechanism through which Australia fulfils its obligations under the United Nations Convention on the Rights of Persons with Disabilities.33 Under the UN Convention, rights should be equitable, so should not be better enjoyed by people with some types of disability or needs over others. Equity decisions should not be outsourced to a market where decisions of profit compete with decisions about equitable service access. In order to ensure equitable disability support, we need to consciously build a disability support system (including the NDIS) that i) ensures that decisions with equity consequences do not rely on the goodwill of service providers but are a product of market design, and ii) that provides a cohesive system structure that enables access to necessary services for people with disability sitting outside the NDIS (including people aged over 65 years). The National Disability Insurance Agency has significant existing powers to make decisions affecting scheme equity through scheme redesign to address underutilisation and, at a micro‐level, through decisions relating to individual participants. Key to realising equity is an adaptive approach to the design of social care markets where all parts of the market are not treated in the same way.26 This approach means that the areas of disability support that work best within a traditional market environment may continue to function in that way but with government directing markets in a proactive way to provide supports for people with complex or unique needs. This could include increased pricing for services for particular groups or locations or appointing providers to deliver services where markets do not emerge to provide services. We urgently need evidence for how this can be done successfully.34 It is critical that issues of equity for people with disability, both within and outside the NDIS, are brought to the fore in the current NDIS review. A failure to address inequity within the operation and design of disability support means that the NDIS will continue to perpetuate the disabling and ableist structures that marginalise people with disability in the Australian society.
Jennifer Smith‐Merry · John Gilroy · Annmaree Watharow
Mitigating the impacts of racism on Indigenous wellbeing through human rights, legislative and health policy reform
System-wide racial discrimination and inequitable access to justice impedes Indigenous rights to health and wellbeing
Pat Dudgeon · Abigail Bray · Roz Walker
Consensus recommendations on the management of hepatitis C in Australia's prisons
Prison settings are risk environments for HCV transmission and should therefore be a priority setting for harm reduction and clinical and educational interventions
Rebecca J Winter · Yumi Sheehan · Timothy Papaluca · Graeme A Macdonald · Joy Rowland · Anton Colman · Mark Stoove · Andrew R Lloyd · Alexander J Thompson
Highlighting equity and inequity in Australia’s health system
Equity and inequity in Australia's health system are major themes in this latest issue of the MJA. From the beginning, when research is funded, through to how clinical guidelines are developed, how research is conducted, and, finally, in health outcomes, the articles in this issue explore gender and racial inequities from several angles, including what progress has been made, and where deficiencies remain. Together they highlight how diversity and inclusivity in generating and applying medical evidence is fundamental to ensuring our health system achieves equitable and high quality outcomes for all patients. In her Perspective Towards gender equity in Australian health and medical research funding, the NHMRC CEO, Professor Anne Kelso, describes an important new initiative by the leading Australian health research funder to reduce gender disparities in one key area: the Leadership levels of the Investigator Grant scheme. This measure, informed by evidence and consultation across the Australian health research sector, is welcome, and is hopefully a start towards reducing the attrition of women at early and mid‐career stages. I was especially heartened to see that its “goals are defined, its effectiveness will be monitored annually, and it will cease if it is found to be ineffective or to have achieved its goals” (doi: 10.5694/mja2.51767). Continuing the theme of gender inequity, Anna Shalit and colleagues found that women were underrepresented in Australian clinical guideline development groups over the 10‐year period, 2010–2020, especially when it comes to women in leadership as panel chairs. The authors recommend that organisations which “develop or endorse guidelines should adopt effective policies for gender balance on their guideline panels and regularly monitor progress toward this target” (doi: 10.5694/mja2.51831). For their Research article on Ethical conduct in research with Aboriginal and Torres Strait Islander peoples and communities, Luke Burchill and colleagues surveyed people working in Indigenous health research in Australia about their use of the 2018 NHMRC guidelines, and the degree of Indigenous governance and participation in their research. Their findings are essential reading for anyone working in Indigenous health. Although the NHMRC guidelines are widely used, along with local guidelines, the authors conclude that “Indigenous governance and participation was inadequate at each stage of research” and that “Indigenous health research in Australia is largely informed by non‐Indigenous world views, led by non‐Indigenous people, and undertaken in non‐Indigenous organisations” (doi: 10.5694/mja2.51757). In their linked editorial, Aboriginal and Torres Strait Islander health research leadership, Candice McKenzie and Lilon Bandler emphasise how sobering these findings are, noting that “As only 38% of [the survey] respondents had received any formal education in the history of health research involving Indigenous people, more than 60% may not have properly understood the historical background underpinning the need for and value of the [NHMRC] guidelines.” They call for more than just a commitment to strengthening capacity building among Aboriginal and Torres Strait Islander health researchers: “We support the development of a required course on the ‘legacy of health research exploiting Indigenous Peoples’ that examines the eight domains of the Consolidated criteria for strengthening the reporting of health research involving Indigenous Peoples (CONSIDER) statement” (doi: 10.5694/mja2.51827). The complex interplay of societal and health system factors that lead to inequitable health outcomes is examined by Paul Secombe and colleagues in their analysis of 12‐month mortality for Indigenous and non‐Indigenous people admitted to intensive care units in Australia. They find that “survival outcomes are poorer for Indigenous than non‐Indigenous people admitted to ICUs”, but conclude that it “is likely that the difference is less directly attributable to the ICU admission than to a complex interplay between pre‐ and post‐hospitalisation factors, socio‐economic disadvantage, remoteness, and chronic disease trajectory”. This is a message that should resonate well beyond this article across the entire Australian health system (doi: 10.5694/mja2.51763). 2023 is likely to be another challenging year for the Australian — and the global — health systems. The MJA team is committed to addressing these challenges in the research and commentary we publish, and look forward to working with authors, reviewers, and other colleagues from across the health community in the year ahead.
Virginia Barbour
Gender diversity of clinical practice guideline panels in Australia: important opportunities for progress
Gender balance can lead to more focused recommendations and better health outcomes for everyone
Cheryl Carcel · Mark Woodward
Supporting Indigenous health equity strategic planning: a Queensland perspective
Queensland’s approach to Indigenous health equity planning and implementation should align with existing international frameworks
Maree R Toombs · Caitlin Curtis · Claire E Brolan
Non‐fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study
Re-introducing public opioid agonist therapy clinics in Victoria could improve accessibility for some people recently released from prison
Michael Curtis · Paul Dietze · Rebecca J Winter · Kasun Rathnayake · Karen Smith · Mark Stoove
Twelve‐month mortality outcomes for Indigenous and non‐Indigenous people admitted to intensive care units in Australia: a registry‐based data linkage study
After adjusting for age and other factors, survival outcomes are poorer for Indigenous than non-Indigenous people admitted to ICUs
Paul J Secombe · Alex Brown · Michael J Bailey · Sue Huckson · Shaila Chavan · Edward Litton · David Pilcher
Health care in police watch‐houses: a challenge and an opportunity
Police watch-house detainees have complex health needs that involve multiple agencies and require coordinated, interagency solutions
Julia L Crilly · Caitlin Brandenburg · Stuart A Kinner · Ed Heffernan · Joshua Byrnes · Cathy Lincoln · Paul Gardiner · Peter Davidson · Annabel Somerville · Daniel Wilson · David Green · Stuart Thomas
Surviving and thriving after breast cancer treatment
Breast cancer commonly causes significant physical and psychological sequelae; guidelines and models of care exist to ameliorate these
Christobel M Saunders · Lesley Stafford · Martha Hickey
Striving for gender equity at the Medical Journal of Australia
Diversity and equity are both imperative when it comes to publishing high quality literature that promotes better health outcomes
Alisha Dorrigan · Elizabeth Zuccala · Nicholas J Talley
Transforming health settings to address gender‐based violence in Australia
For too long gender-based violence has been seen as the domain of social services or justice, with policy failing to resource an integrated response by the health system
Kelsey L Hegarty · Shawana Andrews · Laura Tarzia
Patient‐reported outcome measures (PROMs) to guide clinical care: recommendations and challenges
To the Editor: We read with interest the article by Agarwal and colleagues1 outlining the recommendations from the Health Services Research Association of Australia and New Zealand for implementing patient‐reported outcome measures (PROMs) to guide clinical care. The article regrettably fails to acknowledge that most of the commonly used PROMs — largely developed without direct patient participation — may merely provide a patient‐rated version of a measure that nevertheless reflects the clinician’s or researcher’s, not the patient’s, perspective.2,3 Importantly, “patient‐reported” conveys only that the measurement instrument — usually a scale or questionnaire — is completed by the patient. The emphasis is placed on the source of the information (ie, the patient) rather than on its content. It does not automatically imply that the information thus obtained is necessarily of value or relevance to the patient. As an attempt to shed light on this issue, our group elaborated a classification system for PROMs according to the degree of patient involvement in their development:2 patient‐generated PROMs — a type of PROM developed entirely from the patient perspective, as at all stages of PROM development the researchers are themselves patients; patient‐centred PROMs — a kind of PROM that explicitly incorporates, to a greater or lesser extent, patient priorities, given that patients themselves codeveloped the PROM jointly with other stakeholders (eg, clinicians); patient‐valued PROMs — a variety of PROM developed without patient input but valued by most patients because it reflects, at least in part, their priorities; and patient‐irrelevant PROMs — a type of PROM developed entirely without patient participation, whose contents are evaluated as not relevant by patients themselves. Fortunately, the epistemic injustice of disregarding the patient’s perspective in PROMs development is being progressively abandoned, and there seems to be a growing consensus that patients should be significantly involved — through truly participatory methods — in developing any new PROM.2,4,5 Without genuinely incorporating the patient’s perspective in PROMs development, PROMs collection will not contribute to a true and meaningful involvement of patients in their health care.
Joan Trujols · Santiago Duran‐Sindreu · Maria J Portella
Patient‐reported outcome measures (PROMs) to guide clinical care: recommendations and challenges
In reply
Anupriya Agarwal · Rachael L Morton
Climate, housing, energy and Indigenous health: a call to action
The convergence of excessive heat, poor housing, energy insecurity and chronic disease has reached critical levels
Simon Quilty · Norman Frank Jupurrurla · Ross S Bailie · Russell L Gruen
The need for a roadmap to guide actions for Aboriginal and Torres Strait Islander adolescent health: youth governance as an essential foundation
The current lack of a national strategy for Indigenous adolescent health in Australia is a glaring gap
Seth Westhead · Quinton Appleby · Brittney Andrews · Tina Brodie · Alex Brown · Karla Canuto · Josh Cooke · Mahlia Garay · Thomas Harrington · Djai Hunter · Corey Kennedy · Jaeda Lenoy · Olivia Lester · Hannah McCleary · Odette Pearson · Lorraine Randall · Rachel Reilly · Hamish Rose · Daniel Rosendale · Jakirah Telfer · Peter Azzopardi
Dynamic consent and personalised medicine
Dynamic consent has the potential to facilitate personalised medicine delivering on its goals
Liza Goncharov · Hanna Suominen · Matthew Cook
Taking a broader view of the health care needs of people with chronic kidney disease
To the Editor: We thank Polkinghorne and Kerr1 for their editorial on the health care needs of people with chronic kidney disease (CKD). We write to highlight the burden of visual loss suffered by people with CKD and its effects on quality of life and mortality. The prevalence of eye diseases associated with visual impairment (combined World Health Organization definitions of blindness and low vision) in people with CKD is about 36%, rising to about 60% in people with end‐stage renal disease.2 The commonest causes of visual impairment are diabetic retinopathy (prevalence in patients with CKD, 19–46%), cataract (prevalence, 33–75%) and age‐related macular degeneration (prevalence, 8–36%).2 Increased incidence of retinal vein occlusions and hypertensive retinopathy are also associated with CKD. Patients receiving haemodialysis have increased risk of additional ocular complications. A recent study of 121 patients found at least one ocular finding in over 89% cases, including conjunctival (32%) and corneal (32%) calcification, and optic atrophy (19%).3 Ectopic calcification has been a common cause of irritated eyes in patients receiving dialysis, but this may be decreasing with modern dialysis methods. Increased risk of optic atrophy may be related to chronic anaemia and an increased risk of non‐arteritic anterior ischaemic optic neuropathy. Uraemic optic neuropathy is now an uncommon event. People with CKD are recognised to have an increased risk of dying from heart disease (up to 20 times that of age and gender matched people for people on haemodialysis).4,5 Vision impairment may incrementally contribute to increased mortality; a recent meta‐analysis demonstrated an all‐cause mortality hazard ratio of 1.43 (95% CI, 1.22–1.68) for visual acuity worse than 6/18.6 Vision‐related quality of life is potentially reduced in people with CKD, affecting their ability to complete activities of daily living and their social, emotional and economic wellbeing. Vision loss is associated with increased risk of falls and increased mental health burden, typically anxiety and depression, and may limit the ability to live independently, including self‐medicating with insulin and performing home dialysis. Multiple studies show people rate losing vision as worse than losing hearing, memory, speech or a limb.7 We agree that supportive care clinics for people electing to not receive kidney replacement therapy are important, and suggest that these clinics include regular eye care services.
Heather G Mack · Deborah J Colville · Judith A Savige
COVID‐19 highlights the need for action on pulse oximeter accuracy in people with dark skin
To the Editor: Recently published studies have highlighted concerns that pulse oximeter devices may underestimate hypoxia (overestimate oxygen saturation) in patients with dark skin. This occurs at levels where key decisions are made around supplemental oxygen and hospital admission (arterial oxygen saturation [SaO2] 88–94%). Amid the coronavirus disease 2019 (COVID‐19) pandemic, this important public health issue prompted the Therapeutic Goods Administration (TGA) to publish a medical device safety update.1 Long‐standing concerns about reduced pulse oximeter accuracy in people with dark skin2,3 have evolved into characterisation of significant racial discrepancies. A recent article compared 48097 pairs of measurements by pulse oximetry and arterial blood gas (ABG) in adults receiving oxygen across 179 hospitals in the United States. Among patients saturating >92% on pulse oximetry, hypoxaemia (ABG saturation<88%) was nearly three times more common in black patients than in white patients. Graphs illustrate the median oxygen saturation bias for black patients was 3% in the 89–96% range.4 A recent retrospective cohort study analysed registry SaO2 data in 372 individuals (73.1% with COVID‐19) about to undergo extracorporeal membrane oxygenation for respiratory failure. In patients with pulse oximeter readings of 92–96%, ABG oxygen saturation was <88% in 21.5% of black patients and in 10.2% of white patients.5 In these retrospective audits, patient ethnicity was based on hospital record identification, not skin colour. The oximetry devices used were not specified. COVID‐19 guidelines may incorporate pulse oximeter readings into decisions regarding hospital transfer of home‐care patients. Clinicians and services should arguably have lower thresholds for hospital review and admission of patients with dark skin (including Indigenous Australians and those of African and South Asian descent) with borderline oxygen saturations, while balancing risks of increased ABG and invasive treatment rates. Device manufacturers should develop pulse oximeters that perform accurately across more diverse populations. Further research must identify mechanisms of racial discrepancies in oxygen saturation and address them through device design. Calibration and testing processes for existing devices should be strengthened. The pre‐market approval processes of the US Food and Drug Administration currently require that only 15% of a study population have darker skin, while Australia has no specified requirement. The TGA does not regulate pulse oximeters sold directly to consumers (in stores or online) for general wellness or sporting purposes only. There are significant constraints on the scope for regulatory interventions for medical device pulse oximeters: this essential equipment cannot be excluded from the market or its supply compromised; mandating changes to instructions for use may have limited impact; differentiating between devices is hampered by evidence limitations and any consequent actions would be legally fraught; and mandating accuracy studies would be difficult to enforce. Contemporary evidence demonstrates that dark skin is a risk factor for hypoxia being undetected by pulse oximetry. Clinicians should adjust treatments and guidelines accordingly and consider audits of devices used in their institutions. Failure to address this problem at a design and testing level compromises racial equity in health care outcomes.
Jeffrey J Brownscombe · Heather Loane · Bridget Honan
Reading the fine print: Medicare telehealth changes to disadvantage rural and remote populations
To the Editor: The rapid uptake of telehealth has been a cornerstone of the response to the coronavirus disease 2019 (COVID‐19) pandemic, and has ensured the provision of essential health care despite restrictions and lockdowns. Although not new technology, telehealth has dramatically increased in prominence and received broad acceptance by doctors and patients alike. Given its success, the Australian Government has confirmed the permanent retention of multiple telehealth item numbers within the Medicare Benefits Schedule (MBS).1 However, it is concerning that this announcement also contained the fine print that the long‐standing MBS incentive for providing telepsychiatry consultations to rural and remote patients will be abolished. This is despite patients in rural and remote communities experiencing well established difficulties accessing health care and having poorer outcomes than their metropolitan counterparts.2 Telehealth consultations have occurred in psychiatry since well before the COVID‐19 pandemic, and have filled an important gap in the workforce by increasing services available in rural and remote areas.3 Video‐based consultations are particularly suited to psychiatry as the key skills of history taking, mental state examination, and psychotherapy do not require physical proximity. Delivering diagnostic assessment and psychological treatment via telehealth have long been demonstrated to be effective and tolerable.4,5 The MBS item number 288 was introduced in 2011 as an adjunct billing code that attracted a 50% loading for psychiatric consultations conducted via telehealth for patients located in a rural or remote setting, aged care facility, or Aboriginal health service. This loading incentivised bulk‐billing of these telehealth assessments. The deletion of this item number from 1 January 2022 will likely result in two adverse consequences: i) fewer telepsychiatry consultations to rural and remote locations will be bulk billed, and ii) telepsychiatry appointments that previously were only available for rural and remote patients will increasingly be offered to metropolitan patients. This will ensure fewer and less affordable options. The cessation of the rural loading for telehealth assessments is a retrograde step that is likely to further entrench long‐standing inequities in both access to care and patient outcomes for psychiatric patients who do not live in the cities. The 288 item number should be reinstated or replaced with an alternative funding mechanism to ensure bulk billed consultations continue to be available for rural and remote patients.
Michael J Weightman
Returning raw genomic data: rights of research participants and obligations of health care professionals
As the number of requests for raw genomic data increases, policies and protocols reflecting the perspectives of clinicians, patients, researchers and research participants are required
Jane L Nielsen · Carolyn Johnston · Tracey O'Brien · Vanessa J Tyrrell
Access to abortion services in Australia: we must do better
Clinicians should be mindful of the importance of post-abortion contraception counselling for preventing further unintended pregnancies
Andrew F Pesce · Gayathri Jayasinghe
The need for improved Australian data on social determinants of health inequities
Australia needs better data on health inequities to support building back fairer from the pandemic
Joanne Flavel · Martin McKee · Toby Freeman · Connie Musolino · Helen Eyk · Fisaha H Tesfay · Fran Baum